40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
162.38%
Cash & equivalents growing 162.38% while VET's declined -13.88%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
162.38%
Below half of VET's -13.88%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
-0.08%
Receivables growth less than half of VET's 0.16%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
-100.00%
Inventory growth below half of VET's 10.19%. David Dodd would check if that's due to efficiency or supply constraints.
11.20%
Other current assets growth < half of VET's 22.52%. David Dodd sees a leaner approach to short-term items.
96.09%
Below half of VET's -5.20%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-7.56%
Below half VET's 1.95%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
-22.39%
Higher Goodwill Growth compared to VET's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-22.39%
Higher Goodwill + Intangibles Growth compared to VET's zero value, indicating worse performance.
-32.94%
Both VET and the company show zero Long-Term Investments Growth.
-62.87%
Above 1.5x VET's -0.03%. Michael Burry suspects major tax losses or deferrals building up, raising concerns about sustained profitability.
-19.37%
Higher Other Non-Current Assets Growth compared to VET's zero value, indicating worse performance.
-12.60%
Below half of VET's 1.87%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
13.95%
≥ 1.5x VET's 1.22%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
5.78%
Less than half of VET's 22.52%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
-40.00%
Above 1.5x VET's -0.02%. Michael Burry questions if there's an abrupt jump in tax obligations or poor payment scheduling.
No Data
No Data available this quarter, please select a different quarter.
-80.77%
Exceeding 1.5x VET's -5.32%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-2.16%
Less than half of VET's 14.16%. David Dodd sees a more disciplined short-term liability approach.
-0.57%
Above 1.5x VET's -0.02%. Michael Burry suspects significant leverage additions. Check coverage.
-2.52%
Both VET and the company show zero Non-Current Deferred Revenue Growth.
22.32%
Above 1.5x VET's 2.04%. Michael Burry sees a much bigger deferred tax load building up.
10.40%
Above 1.5x VET's 2.03%. Michael Burry suspects a looming risk from large additions to LT liabilities.
0.95%
1.1-1.25x VET's 0.80%. Bill Ackman questions if the firm is outpacing competitor in long-term leverage.
No Data
No Data available this quarter, please select a different quarter.
0.36%
Less than half of VET's 2.93%. David Dodd sees far fewer liability expansions relative to competitor.
-0.18%
Less than half of VET's 1.06%. David Dodd sees fewer share issuances vs. competitor.
120.52%
Below half VET's -148.56%. Michael Burry suspects major net losses or high dividends vs. competitor.
-8.22%
Less than half of VET's -72.46%. David Dodd sees fewer intangible or market-driven swings than competitor.
0.18%
Higher Other Stockholders' Equity Items Growth compared to VET's zero value, indicating worse performance.
39.51%
Below half VET's -0.79%. Michael Burry sees potential underperformance in building shareholder capital.
13.95%
≥ 1.5x VET's 1.22%. David Dodd sees faster overall balance sheet growth than competitor.
-32.94%
Both VET and the company show zero Total Investments Growth.
-1.84%
Above 1.5x VET's -0.02%. Michael Burry sees a major jump. Investigate leverage rationale.
-79.49%
Less than half of VET's 2.20%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
